The ocular effects of cannabinoids
- PMID: 233656
The ocular effects of cannabinoids
Similar articles
-
Autonomic drugs in ophthalmology: some problems and promises. Section III: Sympathomimetic drugs.Ann Ophthalmol. 1974 Sep;6(9):875-8, 881-4, 887-8. Ann Ophthalmol. 1974. PMID: 4155259 Review. No abstract available.
-
Chemical sympathectomy in glaucoma therapy: an investigation of alpha and beta adrenergic supersensitivity.Ann Ophthalmol. 1973 Jul;5(7):783-96. Ann Ophthalmol. 1973. PMID: 4716948 No abstract available.
-
[Possibilities of applying cannabinoids' in the treatment of glaucoma].Klin Oczna. 2008;110(7-9):314-7. Klin Oczna. 2008. PMID: 19112869 Review. Polish.
-
Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.J Pharmacol Exp Ther. 1993 Nov;267(2):822-7. J Pharmacol Exp Ther. 1993. PMID: 7902435
-
Pattern of ocular response to topical and systemic prostaglandin.Invest Ophthalmol. 1975 Jan;14(1):36-40. Invest Ophthalmol. 1975. PMID: 1110134
Cited by
-
Cannabinoid Receptors CB1 and CB2 Modulate the Electroretinographic Waves in Vervet Monkeys.Neural Plast. 2016;2016:1253245. doi: 10.1155/2016/1253245. Epub 2016 Mar 16. Neural Plast. 2016. PMID: 27069692 Free PMC article.
-
Endocannabinoids in the retina: from marijuana to neuroprotection.Prog Retin Eye Res. 2008 Sep;27(5):501-26. doi: 10.1016/j.preteyeres.2008.07.002. Epub 2008 Aug 3. Prog Retin Eye Res. 2008. PMID: 18725316 Free PMC article. Review.
-
Indirect sympatholytic actions at β-adrenoceptors account for the ocular hypotensive actions of cannabinoid receptor agonists.J Pharmacol Exp Ther. 2011 Dec;339(3):757-67. doi: 10.1124/jpet.111.185769. Epub 2011 Sep 1. J Pharmacol Exp Ther. 2011. PMID: 21885619 Free PMC article.